Identifying Patients Who May Be Candidates for a Clinical Trial of Salvage Accelerated Partial Breast Irradiation after Previous Whole Breast Irradiation

Table 2

Characteristics of 157 local recurrences after whole-breast irradiation.

Clinical T stage
Tis	32 (20.4%)
T1	90 (57%)
T2	14 (9%)
T3/4	13 (9%)
Unknown	8 (5%)
Pathologic T stage
Tis/T1	110 (70%)
T2/3/4	14 (9%)
Unknown	33 (21%)
Location
Unifocal	139 (89%)
Multifocal/diffuse	9 (6%)
Skin involvement	5 (3%)
Unknown	4 (2%)
Time to recurrence
Median (range)	73 mos (7–265)
≤24 months	12 (8%)
>24 months	138 (92%)